Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCMP
401
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $68.9M | 0.05% |
477,363
-200,076
| -30% | -$28.4M |
|
402
PPG Industries
PPG
$25.5B
| $68.7M | 0.05% |
514,653
+46,153
| +10% | +$5.85M |
|
|
MIC
403
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $68.3M | 0.05% |
1,595,400
+18,100
| +1% | +$747K |
|
404
Empire State Realty Trust
ESRT
$807M
| $68.3M | 0.05% |
4,892,292
+72,844
| +2% | +$1.02M |
|
405
Stellantis
STLA
$20.1B
| $68.1M | 0.05% |
4,598,540
+1,799,251
| +64% | +$26M |
|
406
Centene
CNC
$32.9B
| $68.1M | 0.05% |
1,082,700
-1,258,932
| -54% | -$68.3M |
|
407
Teradata
TDC
$2.51B
| $67.7M | 0.05% |
2,529,193
-582,607
| -19% | -$16.2M |
|
|
AHRT
408
AH Realty Trust
AHRT
$500M
| $67.6M | 0.05% |
3,685,809
-48,300
| -1% | -$877K |
|
|
PRO
409
DELISTED
PROS Holdings
PRO
| $67.2M | 0.05% |
1,122,100
-272,100
| -20% | -$15.7M |
|
|
STOR
410
DELISTED
STORE Capital Corporation
STOR
| $66.6M | 0.05% |
1,789,400
+304,000
| +20% | +$11.8M |
|
411
Charter Communications
CHTR
$17.9B
| $66.6M | 0.05% |
137,200
+66,000
| +93% | +$30.4M |
|
|
ALE
412
DELISTED
Allete
ALE
| $66.3M | 0.05% |
817,007
-136,000
| -14% | -$11.3M |
|
413
Sturm, Ruger & Co
RGR
$602M
| $65.9M | 0.05% |
1,400,576
-5,400
| -0.4% | -$245K |
|
414
Equity Residential
EQR
$24.3B
| $65.8M | 0.05% |
+813,700
| New | +$69.3M |
|
415
Ambarella
AMBA
$3.66B
| $65.7M | 0.05% |
1,084,633
+297,407
| +38% | +$16.5M |
|
416
PLDT
PHI
$4.2B
| $65.5M | 0.05% |
3,277,116
+105,762
| +3% | +$2.21M |
|
|
UHT
417
Universal Health Realty Income Trust
UHT
$570M
| $65.5M | 0.05% |
557,910
-9,590
| -2% | -$1.09M |
|
418
Tyson Foods
TSN
$19.7B
| $65.4M | 0.05% |
718,100
+672,500
| +1,475% | +$57.8M |
|
419
L3Harris
LHX
$52.8B
| $65.3M | 0.05% |
330,241
-85,039
| -20% | -$17.1M |
|
420
Shenandoah Telecom
SHEN
$730M
| $65.2M | 0.05% |
1,566,600
+29,200
| +2% | +$1.03M |
|
421
Sun Communities
SUI
$14.4B
| $64.2M | 0.05% |
427,450
-48,900
| -10% | -$7.62M |
|
422
General Dynamics
GD
$106B
| $64.1M | 0.05% |
+363,700
| New | +$65.3M |
|
423
Open Text
OTEX
$5.71B
| $64.1M | 0.05% |
1,454,832
+242,816
| +20% | +$10.2M |
|
|
SKX
424
DELISTED
Skechers
SKX
| $63.9M | 0.05% |
1,479,400
+59,373
| +4% | +$2.34M |
|
425
UGI
UGI
$7.48B
| $63.9M | 0.05% |
1,413,862
-206,688
| -13% | -$9.47M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.